Aurobindo Settles Medicis Patent Suit Over Solodyn

Law360, New York (September 15, 2011, 2:09 PM EDT) -- Aurobindo Pharma Ltd. on Wednesday became the latest generics maker to settle patent infringement litigation from Medicis Pharmaceutical Corp. over acne drug Solodyn.

U.S. District Judge Leonard P. Stark signed off on the deal, bringing to a close a suit Medicis filed in December claiming that Aurobindo's proposed generic version of Solodyn infringed two patents.

"Final settlement of the litigation will help Medicis and defendants avoid the substantial uncertainty and risks involved with prolonged litigation," the judge wrote.

Under the terms of a settlement and license...
To view the full article, register now.